The Ancestral N-Terminal Domain of Big Defensins Drives Bacterially Triggered Assembly into Antimicrobial Nanonets by Loth, Karine et al.
HAL Id: hal-02328576
https://hal.archives-ouvertes.fr/hal-02328576
Submitted on 23 Oct 2019
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
The Ancestral N-Terminal Domain of Big Defensins
Drives Bacterially Triggered Assembly into
Antimicrobial Nanonets
Karine Loth, Agnès Vergnes, Cairé Barreto, Sébastien Voisin, Hervé Meudal,
Jennifer da Silva, Albert Bressan, Nawal Belmadi, Evelyne Bachère, Vincent
Aucagne, et al.
To cite this version:
Karine Loth, Agnès Vergnes, Cairé Barreto, Sébastien Voisin, Hervé Meudal, et al.. The Ancestral N-
Terminal Domain of Big Defensins Drives Bacterially Triggered Assembly into Antimicrobial Nanonets.
mBio, American Society for Microbiology, 2019, 10 (5), pii: e01821-19. ￿10.1128/mBio.01821-19￿. ￿hal-
02328576￿
The Ancestral N-Terminal Domain of Big Defensins Drives
Bacterially Triggered Assembly into Antimicrobial Nanonets
Karine Loth,a,b Agnès Vergnes,c Cairé Barreto,c,d Sébastien N. Voisin,e Hervé Meudal,a Jennifer Da Silva,f Albert Bressan,c,d
Nawal Belmadi,f Evelyne Bachère,c Vincent Aucagne,a Chantal Cazevielle,g Hélène Marchandin,h Rafael Diego Rosa,d
Philippe Bulet,e,i Lhousseine Touqui,f Agnès F. Delmas,a Delphine Destoumieux-Garzónc
aCentre de Biophysique Moléculaire UPR4301 CNRS, Orléans, France
bUFR CoST, Université d’Orléans, Orléans, France
cIHPE, Université de Montpellier, CNRS, Ifremer, Université de Perpignan Via Domitia, Montpellier, France
dLaboratory of Immunology Applied to Aquaculture, Department of Cell Biology, Embryology and Genetics, Federal University of Santa Catarina, Florianópolis,
Santa Catarina, Brazil
ePlateforme BioPark d’Archamps, Archamps Technopole, Archamps, France
fEquipe mixte Institut Pasteur/Paris V Mucoviscidose et Bronchopathies Chroniques, Institut Pasteur, Paris, France
gCOMET, Plateau de microscopie électronique, Plateforme Montpellier RIO Imaging, Montpellier, France
hHydroSciences Montpellier, Département de Microbiologie, CHU Nîmes, CNRS, IRD, Université de Montpellier, Nîmes, France
iInstitute for Advanced Biosciences, CR Université Grenoble Alpes, CNRS UMR5309, La Tronche, France
ABSTRACT Big defensins, ancestors of -defensins, are composed of a -defensin-
like C-terminal domain and a globular hydrophobic ancestral N-terminal domain.
This unique structure is found in a limited number of phylogenetically distant spe-
cies, including mollusks, ancestral chelicerates, and early-branching cephalochor-
dates, mostly living in marine environments. One puzzling evolutionary issue con-
cerns the advantage for these species of having maintained a hydrophobic domain
lost during evolution toward -defensins. Using native ligation chemistry, we pro-
duced the oyster Crassostrea gigas BigDef1 (Cg-BigDef1) and its separate domains. Cg-
BigDef1 showed salt-stable and broad-range bactericidal activity, including against
multidrug-resistant human clinical isolates of Staphylococcus aureus. We found that the
ancestral N-terminal domain confers salt-stable antimicrobial activity to the -defensin-
like domain, which is otherwise inactive. Moreover, upon contact with bacteria, the
N-terminal domain drives Cg-BigDef1 assembly into nanonets that entrap and kill bacte-
ria. We speculate that the hydrophobic N-terminal domain of big defensins has been re-
tained in marine phyla to confer salt-stable interactions with bacterial membranes in en-
vironments where electrostatic interactions are impaired. Those remarkable properties
open the way to future drug developments when physiological salt concentrations in-
hibit the antimicrobial activity of vertebrate -defensins.
IMPORTANCE -Defensins are host defense peptides controlling infections in spe-
cies ranging from humans to invertebrates. However, the antimicrobial activity of
most human -defensins is impaired at physiological salt concentrations. We ex-
plored the properties of big defensins, the -defensin ancestors, which have been
conserved in a number of marine organisms, mainly mollusks. By focusing on a big
defensin from oyster (Cg-BigDef1), we showed that the N-terminal domain lost dur-
ing evolution toward -defensins confers bactericidal activity to Cg-BigDef1, even at
high salt concentrations. Cg-BigDef1 killed multidrug-resistant human clinical isolates
of Staphylococcus aureus. Moreover, the ancestral N-terminal domain drove the as-
sembly of the big defensin into nanonets in which bacteria are entrapped and killed.
This discovery may explain why the ancestral N-terminal domain has been main-
tained in diverse marine phyla and creates a new path of discovery to design
-defensin derivatives active at physiological and high salt concentrations.
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-Defensins are essential components of innate immunity broadly found in verte-brates and invertebrates (1). Through their multiple functions (e.g., as antimicrobial
peptides [AMPs], proinﬂammatory mediators of the immune response), these cationic
host defense peptides (HDPs) contribute to protection against infections at almost all
human epithelial surfaces (2, 3). Some human -defensins were shown to compromise
bacterial membrane integrity (4). However, like many human (5–7) and avian (8)
-defensins, direct antimicrobial activity at physiological salt concentrations is signiﬁ-
cantly impaired. This suggests that electrostatic interactions initiating interactions
between these cationic peptides and the negatively charged membranes of bacteria (9)
are altered by salts.
Big defensins are a group of AMPs related to -defensins, initially isolated from the
hemocytes of a marine chelicerate, the horseshoe crab (Tachypleus tridentatus) (Tt-
BigDef) (10). They contain a N-terminal hydrophobic domain and a C-terminal
-defensin-like domain (11). The two domains are encoded by separate exons (12, 13).
On the basis of their gene structure and amino acid sequence and three-dimensional
(3D) structure similarities, it was proposed that vertebrate -defensins originated from
an ancestral big defensin via intronization of exonic sequences or exon shufﬂing,
thereby losing the ancestral N-terminal domain (1, 13). Big defensins have been
predominantly described in marine organisms, mainly mollusks (12, 14), and, to a much
lower extent, in ancestral chelicerates (horseshoe crabs) (10) and early-branching
chordates (amphioxus) (15). The evolutionary advantage for those phylogenetically
distant species of having conserved the N-terminal hydrophobic domain represents
one puzzling unsolved issue.
Although they were isolated more than 20 years ago (10), technical limitations
impeding the production of sufﬁcient quantities of big defensins have precluded
investigations on their structure and antimicrobial activities and of the roles of their
respective domains. Sufﬁcient amounts of native Tt-BigDef were obtained from horse-
shoe crab hemocytes to determine its 3D structure (Protein Data Bank [PDB] identiﬁer:
2RNG), which remains the only one solved to date. Tt-BigDef is tightly packed in
solution: the hydrophobic N-terminal domain adopts a 1-1-2-2 fold, whereas the
cationic C-terminal domain shows the cysteine pairing expected for -defensins (11). To
date, data on big defensin antimicrobial activities remain scarce (10, 14, 15).
Achievements that opened the way to structure and activity studies in big defensins
included developments in peptide chemistry related to native chemical ligation (NCL)
strategies (16, 17). Using this methodology, we synthetized Cg-BigDef1, one of the
best-characterized big defensins in terms of gene structure, expression, and role in
immunity (12, 18–20). We obtained several dozen milligrams, solved its solution
structure, and investigated its interactions with bacteria. By using a combination of
antimicrobial assays, immune detection, scanning electron microscopy, and mass
spectrometry analyses, we determined that Cg-BigDef1 is a highly salt-stable AMP that
entraps and kills bacteria in nanonet structures. Moreover, we found that Cg-BigDef1 is
(i) active against clinical strains of Staphylococcus aureus multiresistant to antibiotics,
which represent a major concern for human health, and (ii) devoid of cytotoxicity
toward mammalian cells. Our ﬁndings pave the way for future drug developments
inspired by the evolution-based molecular design of big defensins.
RESULTS
Big defensins are mainly found in marine organisms. We performed an exhaus-
tive search for sequences containing a -defensin domain in publicly available genomic
and transcriptomic databases. Sequences of -defensins were found in diverse groups
of vertebrates (from ﬁsh to mammals) and invertebrates (mollusks and crustaceans),
whereas big defensins were present in a limited number of species belonging to
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Lophotrochozoa, Arthropoda, and Cephalochordata (Fig. 1). Remarkably, of the 78
obtained distinct big defensins, only one sequence (GenBank accession no. AEP26934)
was found in a nonmarine species, the sequence corresponded to the freshwater
mussel Hyriopsis cumingii (21). Mollusks (Lophotrochozoa) represented the superphy-
lum containing the highest diversity of big defensins by far (see Fig. S1 in the
supplemental material). Multiple-sequence alignments revealed a canonical conserved
motif but differently spaced cysteines for big defensins [Cys-Xaa(4–14)-Cys-Xaa(3)-Cys-
Xaa(13–14)-Cys-Xaa(4–7)-Cys-Cys] and -defensins [Cys-Xaa(4–6)-Cys-Xaa(3–4)-Cys-Xaa(7–12)-
Cys-Xaa(5–7)-Cys-Cys] (Fig. 1). The two defensin families also differed by the presence of
a hydrophobic N-terminal domain (20 to 64 residues) in big defensins only (Fig. 1). This
domain, which contains some highly conserved amino acids (Fig. 1), does not show any
homology with sequences present in public databases outside big defensins.
Native chemical ligation-based chemical synthesis gives access to the explo-
ration of multiple-domain Cg-BigDef1 structure and activity. To explore the role of
the ancestral N-terminal domain in big defensin structure and activity, we focused on
the mollusk big defensin Cg-BigDef1 (GenBank accession no. AEE92768). We ﬁrst
synthesized the entirety of Cg-BigDef1. Cg-BigDef1[1–93] corresponds to mature Cg-
BigDef1 with a pyroglutamic acid (Pca) at the N terminus, an amidated C terminus, and
six cysteines involved in three disulﬁde bridges (12) (Table 1). Total synthesis of
Cg-BigDef1 (Fig. 2) was achieved through NCL (16) of Cg-BigDef1[57–93] with a
Cg-BigDef1[1–56] cryptothioester (22) and subsequent oxidative folding (Fig. S2d). The
resulting peptide was characterized by liquid chromatography-mass spectrometry
(LC-MS) (Fig. S2e) and nuclear magnetic resonance (NMR) spectroscopy (see below).
FIG 1 Amino acid sequence alignments of big defensins and -defensins. Conserved residues are highlighted in black. Arrows indicate the six cysteine residues
that follow the canonical cysteine spacing of -defensins and big defensins. The schematic representation (not to scale) shown at the top of the alignments
indicates the structural domain organization of mature big defensins and -defensins. Cysteine pairing is indicated by black lines based on previously reported
data (10, 53) and our NMR data (this study).
TABLE 1 Sequence of Cg-BigDef1 and its two separated domains
Name Sequencea
Cg-BigDef1[1–93] ZAQALLPIASYAGLTVSAPVFAALVTVYGAYALYRYNIRRRENSYQRIRSDHDSHSCANNRGWCRPTCFSHEYTDWFNNDVCGSYRCCRPGRR-NH2
Cg-BigDef1[1–42] ZAQALLPIASYAGLTVSAPVFAALVTVYGAYALYRYNIRRRE-NH2
Cg-BigDef1[44–93] SYQRIRSDHDSHSCANNRGWCRPTCFSHEYTDWFNNDVCGSYRCCRPGRR-NH2
aProteogenic amino acids are abbreviated using the one-letter code; Z is the pyroglutamic acid or pyrrolidinocarboxilic acid (also abbreviated “Pca” with the three-
letter code); the C terminus is amidated. The underlined cysteinyl residues (C) are involved in disulﬁde bonds.
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Cg-BigDef1[1–42] and Cg-BigDef1[44–93], which correspond to the N-terminal and
C-terminal domains of Cg-BigDef1, respectively (Table 1), were synthesized by solid-
phase peptide synthesis according to the position of Cg-bigdef1 exons (12) (Fig. S2a
to c).
Cg-BigDef1 adopts a highly compact hydrophobic fold in solution. The 3D
structures of Cg-BigDef1[1–93] and Cg-BigDef1[44–93] were determined by NMR spec-
troscopy (Tables S1 and S2). Cg-BigDef1[1–93] is composed of two distinct globular
domains connected by a ﬂexible linker (Fig. 3). The N-terminal domain (Pca1 to Glu42)
is hydrophobic and adopts a 1-1-2-2 fold. A hydrophobic core composed of
residues Tyr11, Val16, Val20, Leu24, Leu33, and Ile38 stabilizes this highly compact fold.
The C-terminal domain adopts a -defensin-like fold with a cysteine pairing identical to
that of -defensins (C1-C5, C2-C4, and C3-C6), although the cysteine spacings differ; it
also displays a typical four-stranded antiparallel -sheet and an -helix (Fig. 3). The
linker is composed of 10 residues (Asn43 to His52) and is located at the interface of the
two globular domains (strong polar contacts are formed during the structure calcula-
tion as follows: Arg49/Thr15, Asp51/Ser54, His52/Asp53, Arg65/Asp51, and His71/
Asn43). This allows Cg-BigDef1[1–93] to be highly compact in solution.
We found that the fold of Cg-BigDef1[44–93] is identical to that of the C-terminal
domain of Cg-BigDef1[1–93] except for the ﬁrst nine residues (44 to 52), viz., the linker,
as the network of polar contacts cannot be formed in the absence of the N-terminal
domain (Fig. S3 and S4). The surface of Cg-BigDef1[1–93] is mainly hydrophobic, with
no amphipathic properties. Indeed, all the positively charged residues (Arg35, Arg39,
Arg40, and Arg41) of the N-terminal domain are exposed at the surface. Arg39 is
surrounded by four tyrosine residues (Tyr28, Tyr31, Tyr34, and Tyr36) forming a
hydrophilic patch. Arg40 and Arg41 create an extended hydrophilic belt at the interface
between the -sheet of the hydrophobic domain, the linker, and the C-terminal domain
(Ser10, Thr15, Arg40, Arg41, Glu42, Arg47, Arg49, Ser50, Asp51, His52, Asp53, Thr67,
Ser70, His71, and Arg92). The C-terminal domain (net charge, 3) exhibits three
positively charged residues (Arg61, Arg89, and Arg91) and two negatively charged
acidic residues (Asp53 and Asp80) at the surface, the other charged residues being
buried. Overall, the N-terminal domain does not alter the fold of the conserved
-defensin-like domain but confers hydrophobic properties to this molecule, which is
otherwise mainly hydrophilic.
Cg-BigDef1 has broad range bactericidal activity. Cg-BigDef1 antimicrobial ac-
tivities were tested at 150 mM NaCl and 400 mM NaCl, physiological salt concentrations
for humans and marine bacteria, respectively (Table 2). Cg-BigDef1 was active against
a range of reference, environmental, oyster, and human clinical strains, with various
proﬁles of susceptibility to antibiotics (see Table S3 in the supplemental material). The
lowest minimal inhibitory concentrations (MICs) were observed against Gram-positive
strains (Table 2). All S. aureus strains tested, including methicillin-resistant S. aureus
(MRSA) clinical isolates from cystic ﬁbrosis (CF) and non-CF patients, were susceptible
to Cg-BigDef1 (MICs in the 1.25 to 5 M range). Vibrio isolates, including V. tasmaniensis
FIG 2 Synthetic scheme of Cg-BigDef1. The N-terminal cysteine-containing peptide Cg-BigDef1[58-93] (CANNRGWCRPTCFS
HEYTDWFNNDVCGSYRCCRPGRR) and the Cg-BigDef1[1–56] peptide (ZAQALLPIASYAGLTVSAPVFAALVTVYGAYALYRYNIRRRENS
YQRIRSDHDSHS [“Z” being pyroglutamic acid]) equipped with our thioesteriﬁcation device [(Hnb)Cys(StBu)-Gly-NH2] reacted
under standard NCL conditions (22). After puriﬁcation, the reduced form of Cg-BigDef1[1–93] was engaged in oxidative folding
under thermodynamical control conditions (see Fig. S2). Percentages represent yields after HPLC puriﬁcation.
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and V. crassostreae strains pathogenic for oysters, were inhibited in the 1.25 to 10 M
range. Full inhibition of human clinical isolates of Pseudomonas and Burkholderia was
not reached at the highest concentration tested. A bactericidal effect against most
susceptible strains was determined with minimum bactericidal concentrations (MBCs)
in the range of 0.6 to 10 M (Table 2).
FIG 3 Solution structure of Cg-BigDef1 (PDB entry 6QBL). The global fold and surface potentials of Cg-BigDef1[1–93] are displayed.
(A) Cg-BigDef1[1–93] sequence. “Z” stands for pyroglutamic acid (Pca) and NH2 for the C-terminal amidation. Cysteine residues are
indicated in bold and their pairing by black lines. The secondary structure elements of the protein are indicated below the sequence
in yellow, red, and green for -strand, -helix, and coil, respectively. The N-terminal domain (Pca1 to Glu42) is hydrophobic and
adopts a 1-1-2-2 fold (1, Thr15-Val16; 1, Ala18-Val27; 2, Gly29-Arg35; 2, Arg39-Arg40). The C-terminal domain adopts a
-defensin-like fold (Cys57-Cys87, Cys64-Cys82, Cys68-Cys88), a four-stranded antiparallel -sheet (3, Ser56-Cys57; 4, Gly62-
Arg65; 5, His71-Asp75; 6, Tyr86-Pro91), and an -helix (3, Trp76-Cys82). (B) Superimposition of the 10 models representative of
Cg-BigDef1[1–93] solution structure with a root mean square deviation (RMSD) at 0.567 Å. (C) Electrostatic positive (blue) and
negative (red) areas calculated at the Connolly surface by the use of the Adaptive Poisson-Boltzmann Solver (APBS) (54). (D)
Hydrophobic (yellow) and hydrophilic (green) potential areas calculated at the Connolly surface by the use of the Platinum (55).
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Covalent association of Cg-BigDef1 domains is essential for salt-stable antimi-
crobial activity. The separate domains were markedly less bactericidal than full-length
Cg-BigDef1 (Table 2). Synergies between the two domains were therefore measured by
exposing bacteria to Cg-BigDef1[1–42] and Cg-BigDef1[44–93] simultaneously or to
Cg-BigDef1[1–93]. The separate domains acted synergistically against both Gram-
positive and Gram-negative strains, with fractional inhibitory concentration (FIC) index
values in the 0.625 to 0.740 range (i.e., 1) (Table 3). Strong synergy was observed
when domains were linked covalently (FIC values in the 0.067 to 0.154 range; 0.5)
(Table 3). This shows that the antimicrobial activity of the -defensin domain
TABLE 2 Antimicrobial activities of the full Cg-BigDef1 and its isolated domainsa
Strain Source
[NaCl]
(mM)
Cg-BigDef1[1–93] Cg-BigDef1[1–42] Cg-BigDef1[44–93]
MIC (M) MBC (M) MIC (M) MBC (M) MIC (M) MBC (M)
Gram-negative bacteria
Aliivibrio ﬁscheri 7P_21 Env 400 10 10 10 10 10 10
Burkholderia multivorans 12/11/13-B-2333 Clin/h 150 10 10 10 10 10 10
Escherichia coli MC4100 Ref 150 10 10 10 10 10 10
Pseudomonas aeruginosa ATCC 9027 Ref 150 10 10 10 10 10 10
Pseudomonas aeruginosa (Pa25) 13/07/11-B-3003 Clin/h 150 10 10 10 10 10 10
Pseudomonas aeruginosa (Pa02) 12/07/11-B-2011 Clin/h 150 10 10 10 10 10 10
Vibrio tasmaniensis LGP32 Clin/o 400 10 10 10 10 10 10
Vibrio tasmaniensis 3T8_11 Clin/o 400 10 10 20 10 10 10
Vibrio tasmaniensis 7G7_3 Clin/o 400 5 20 10 10 10 10
Vibrio crassostreae 7T4_12 Clin/o 400 5 10 20 10 10 10
Vibrio crassostreae 7F5_29 Clin/o 400 1.25 1.25 10 10 5 10
Vibrio orientalis 8F5_42 Env 400 10 10 20 10 10 10
Vibrio breoganii 7F1_16 Clin/o 400 10 10 20 10 20 10
Vibrio harveyi 7G5_1 Clin/o 400 10 10 10 10 10 10
Gram-positive bacteria
Corynebacterium stationis CIP 101282 Ref 400 0.15 0.6 2.5 10 2.5 10
Microbacterium maritypicum CIP 105733T Ref 400 10 10 20 10 10 10
Micrococcus luteus CIP 53.45 Ref 150 0.3 1.25 2.5 10 10 10
Staphylococcus aureus (MRSA) strain 7877 Clin/h 150 2.5 5 10 10 10 10
Staphylococcus aureus (MRSA) strain 53863 Clin/h 150 2.5 10 10 10 10 10
Staphylococcus aureus (MRSA) 31/01/14-B-5284 Clin/h 150 1.25 10 10 10 10 10
Staphylococcus aureus (MRSA, GISA) 24/11/08-B-1347 Clin/h 150 2.5 10 10 10 10 10
Staphylococcus aureus (MSSA) 07/02/14-B-5264 Clin/h 150 5 10 10 10 10 10
Staphylococcus aureus Newman Ref 150 2.5 10 10 10 10 10
Staphylococcus aureus SG511 Ref 150 1.25 10 10 10 10 10
aMIC values (reported in micromoles per liter [M]) refer to the minimal concentration required to achieve 100% growth inhibition. MBC values (reported in
micromoles per liter) refer to the minimal concentration required to kill 100% of bacteria. The NaCl concentrations at which assays were performed are indicated in
millimoles per liter (mM). The origin of the clinical and environmental isolates is speciﬁed in Table S3. Env, environmental isolate; Clin, clinical isolate from either
human (Clin/h) or oyster (Clin/o); Ref, reference strain; NT, not tested; CIP, Collection de l’Institut Pasteur; ATCC, American Type Culture Collection; MSSA, methicillin-
susceptible Staphylococcus aureus; MRSA, methicillin-resistant Staphylococcus aureus; GISA, glycopeptide-intermediate Staphylococcus aureus.
TABLE 3 FIC index values of the N- and C-terminal domains of Cg-BigDef1a
Strain
FIC index
Covalently linked
domains
Separate
domains
Staphylococcus aureus SG511 0.156 0.625
Corynebacterium stationis CIP 101282 0.067 0.740
Micrococcus luteus CIP 53.45 0.135 0.750
Vibrio crassostreae 7F5_29 0.125 0.750
aThe synergies of the N- and C-terminal domains were measured as described previously (51) by incubating
either both domains or the full-length Cg-BigDef1 (i.e., covalently linked domains) with bacterial
suspensions of 4 strains displaying the lowest MICs for Cg-BigDef1[1–93]. Results are expressed as FIC index
values according to the following formula: FIC  (N-ter)/MICN-ter  (C-ter)/MICC-ter, where MICN-ter and
MICC-ter are the MICs of the N- and C-terminal domains tested alone and (N-ter) and (C-ter) are the MICs of
the two peptides tested in combination. FIC index values are interpreted as follows: 0.5, strong synergy;
0.5 to 1, synergy; 1 to 2: additive effect; 2, no effect; 2, antagonism.
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September/October 2019 Volume 10 Issue 5 e01821-19 mbio.asm.org 6
 o
n
 O
ctober 23, 2019 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
Cg-BigDef1[44–93] is dependent on a covalent association with the N-terminal Cg-
BigDef1[1–42] domain.
Next, we focused our subsequent studies on S. aureus, which was highly sensitive to
Cg-BigDef1 activity. We showed that Cg-BigDef1[1–93] was bactericidal up to 300 mM
NaCl against both the laboratory strain S. aureus Newman and the multidrug-resistant
S. aureus clinical isolates 7877 and 53863 (Fig. 4A). At 5 M, Cg-BigDef1[1–93] was
bactericidal against S. aureus Newman in the range of 0 to 300 mM NaCl whereas NaCl
by itself had no effect on bacterial growth (Fig. 4B). A bactericidal effect was recorded
for Cg-BigDef1[1–42] in the absence of NaCl as a consequence of raising the peptide
concentration to 20 M. This effect was lost at concentrations over 100 mM NaCl
(Fig. 4B). No bactericidal activity was recorded for 20 M Cg-BigDef1[44–93] in the NaCl
concentration range of 0 to 300 mM (Fig. 4B). Therefore, unlike its separate domains,
Cg-BigDef1[1–93] shows salt-stable bactericidal activity.
Cg-BigDef1 entraps bacteria in nanonets without inducing membrane permea-
bilization. We further explored the mechanism of action of Cg-BigDef1 on S. aureus.
Cg-BigDef1[1–93] killed cells of the SG511 reference strain at 1.25 M, with a 2-log
reduction in colony-forming unit (CFU) counts after 2 h. At 10 M, no CFU could be
counted after 60 min (Fig. 5A) and no membrane permeabilization was detected
(Fig. 5B). Therefore, Cg-BigDef1 bactericidal activity is independent of membrane
permeabilization in S. aureus. Remarkably, by observing Cg-BigDef1-treated S. aureus by
scanning electron microscopy (SEM), we found that Cg-BigDef1[1–93] undergoes in-
tense ﬁbrilar aggregation upon contact with bacteria. Bacterial cells were entrapped in
highly branched nanonets and/or covered with large ﬁbers that adhered to the
bacterial surfaces when incubated with 5 M Cg-BigDef1[1–93] (Fig. 6A). Such struc-
tures were not observed in the absence of bacteria (data not shown), which indicates
that bacteria play an essential role in triggering their assembly. Similar structures were
observed when bacteria were incubated with 5 M Cg-BigDef1[1–42] but not when
FIG 4 Cg-BigDef1 antimicrobial activity is stable at high salt concentrations. (A) Effect of NaCl (0 and 300 mM) on the bactericidal activity of various
concentrations of Cg-BigDef1[1–93] against laboratory S. aureus strain Newman and two cystic ﬁbrosis clinical isolates of S. aureus (strain 7877 and strain 53863).
(B) Effect of increasing NaCl concentrations on the antibacterial activity of Cg-BigDef1[1–93] at 5 M, Cg-BigDef1[1–42] at 20 M, and Cg-BigDef1[44–93] at
20 M against S. aureus Newman. Bacterial cells were incubated with the indicated peptides (gray bars) or the corresponding solvents (black bars) in killing
buffer (KB) in the presence of 0, 20, 100, or 300 mM NaCl. After 2 h, bacterial suspensions were serially diluted with phosphate-buffered saline (PBS) and aliquots
were streaked on Luria-Bertani (LB) agar plates and incubated for 24 h at 37°C. Bactericidal effects were monitored by counting the bacterial CFU on LB agar
plates and expressed either as percent killing compared with that seen with treatment without the antimicrobial peptide (A) or as CFU counts per milliliter (B).
ND, not detected (100 CFU per milliliter).
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they were incubated with -defensin-like Cg-BigDef1[44–93] (5 M) (Fig. 6A). This
supramolecular assembly is consistent with the loss of solubility of Cg-BigDef1[1–93]
and Cg-BigDef1[1–42] after 30 min of contact with S. aureus (Fig. S5 in the supplemen-
tal material). By using polyclonal antibodies raised against Cg-BigDef1[1–93], we ob-
served intense immune staining of large areas surrounding S. aureus under conditions
of incubation with Cg-BigDef1[1–93] (5 M) (Fig. 6B). This showed that the observed
ﬁbers represented Cg-BigDef1[1–93] nanonets. Confocal sections revealed the absence
of immune staining at positions occupied by bacterial cells, showing that Cg-BigDef1[1–
93] did not enter bacteria intracellular space, at least during 30 min of contact (Fig. 6B).
Cg-BigDef1 is neither cytotoxic nor proinﬂammatory toward mammalian cells.
We ﬁnally examined Cg-BigDef1 and its separate domains for potential toxic and/or
proinﬂammatory effects on eukaryotic cells. None of the three peptides were toxic
toward bronchial epithelial cell line IB3 isolated from CF patients, as they did not induce
any detectable release of lactate dehydrogenase compared to the 100% release seen in
the Triton X-100 positive control (Fig. 7A). Moreover, they did not induce a proinﬂam-
matory response in mouse alveolar macrophage cell line J774. Indeed, none of the
peptides triggered secretion of keratinocyte-derived protein chemokine (KC) (Fig. 7B),
the mouse homologue of interleukin-8 (IL-8) known to induce neutrophil chemot-
actic activity (23), leading to the accumulation of these cells in the site of infection.
Similar results were obtained for IL-1 (Fig. 7C), which promotes bacterial killing by
alveolar macrophages (24). In contrast, infection of J774 cells by Pseudomonas
aeruginosa PAO1 (positive control) led to high levels of secretion of both KC and
IL-1 (Fig. 7B and C).
FIG 5 Cg-BigDef1 bactericidal activity is not coupled to membrane permeabilization. (A) The time course
of Cg-BigDef1 killing of S. aureus SG511 was measured over 120 min at two Cg-BigDef1 concentrations
(1.25 M [black symbols] and 10 M [gray symbols]). In a control experiment, Cg-BigDef1 was replaced
by an equal volume of water (white squares). At time zero, cultures were adjusted to 105 CFU/ml. CFU
were then counted by plating at 10, 20, 30, 60, and 120 min. In this assay, the limit of detection was 100
CFU/ml. (B) Membrane permeabilization of S. aureus SG511 was measured by the Sytox green assay.
Bacteria were exposed to 1.25 or 10 M Cg-BigDef1 or an equal volume of water (control). Data are
represented as percentages of permeabilized bacterial cells relative to complete cell lysis with Triton
X-100 as a positive control. In both assays, standard deviations were calculated using results from three
independent experiments.
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DISCUSSION
During evolution, the activity of -defensins has broadened beyond direct antimi-
crobial action such that in mammals, some peptides have adopted a series of additional
functions in immunity (e.g., immune modulation, chemoattraction) and reproduction;
they are currently considered to represent multifunctional HDPs rather than solely
AMPs (3, 25). Here, by studying big defensins, the ancestors of -defensins, we
FIG 6 The N-terminal domain drives bacterially triggered assembly of Cg-BigDef1 into nanonets. (A)
SEM observation of Cg-BigDef1 nanonets. Large and branched ﬁbers entrapping S. aureus SG511 were
observed in S. aureus samples subjected to 24 h of exposure to 5 M Cg-BigDef1[1–93] or Cg-BigDef1[1–
42] but not 5 M Cg-BigDef1[44–93], which is indistinguishable from the no-peptide control results (not
shown). (B) Immune staining of Cg-BigDef1 nanonets in contact with S. aureus SG511. Confocal
microscopy images were acquired after 30 min of contact between bacteria and peptides. DNA was
stained with DAPI (blue), and Cg-BigDef1 was stained with polyclonal antibodies (anti-Cg-BigDef1)
revealed with a secondary antibody coupled to Alexa Fluor 488 (green). Merged images show that space
occupied by S. aureus cells is left empty by Cg-BigDef1 nanonets. Bars represent 3 m.
FIG 7 Cg-BigDef1 is neither cytotoxic nor proinﬂammatory toward eukaryotic cells. (A) Cytotoxicity assay. NCI-H292 cells were
incubated with 5 M Cg-BigDef1[1–93], 20 M Cg-BigDef1[1–42], or 20 M Cg-BigDef1[44–93]. The release of lactate dehy-
drogenase (LDH) by the cells was measured after 24 h using the CytoTox 96 nonradioactive cytotoxicity assay (Promega). Triton
X-100 (1%) was used as a positive control (100% LDH release). Untreated cells were used as a negative control (Ctrl). Data are
expressed as a percentage of the total LDH release compared to cells treated with Triton X-100 (for more details, see reference
22). (B and C) Proinﬂammatory assays. Macrophage cells (cell line J774) were incubated with peptides at the same
concentrations. Secretion of KC (B) and IL-1 (C) was measured after 24 h using DuoSet ELISA kits as previously described (24).
As a positive control for cytokine/chemokine secretion, J774 cells were infected with P. aeruginosa PAO1 (multiplicity of
infection [MOI] 1:1).
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uncovered unique physicochemical properties essential for their ancestral antimicrobial
activity. These properties have been lost during evolution toward -defensins but have
been preserved in a limited number of marine species.
We found that oyster Cg-BigDef1 has conserved salt-stable antimicrobial activity.
Indeed, Cg-BigDef1 showed a broad spectrum of activity in the 1 to 10 M range, even
at high salt concentrations. It was active at up to 300 mM NaCl against human
pathogens and 400 mM NaCl against oyster pathogens (marine microorganisms). The
two domains of Cg-BigDef1 did not display complementary spectra of activities, as
initially proposed for the horseshoe crab Tt-BigDef (10). Instead, they were highly
synergistic, highlighting the importance of their covalent association for the whole
peptide activity. NMR data revealed that oyster Cg-BigDef1, like horseshoe crab Tt-
BigDef (26), possesses two structural domains. The hydrophobic N-terminal domain
adopts a unique globular fold, and the C-terminal domain adopts a -defensin-like
conformation. The two domains are in close contact, giving rise to a very compact 3D
structure in solution. While cationic and anionic patches are displayed at the surface of
Cg-BigDef1, the overall structure is mainly hydrophobic and does not display the typical
amphipathic structure of cationic AMPs (27). This has important consequences for
Cg-BigDef1 interactions with bacteria, which were shown to require the hydrophobic
N-terminal domain and are not impaired at high salt concentrations. This suggests that
Cg-BigDef1 interacts with bacterial membranes through hydrophobic interactions
rather than electrostatic interactions.
The 3D structure of Cg-BigDef1 is only the second from the big defensin family. It
differs from Tt-BigDef by exhibiting a longer linker and a different orientation of the N-
and C-terminal domains (Fig. 8). By modifying the orientation of the domains, we found
that linkers drastically modiﬁed the surface properties of big defensins. Indeed, Tt-
BigDef is amphipathic whereas Cg-BigDef1 is hydrophobic. Whether this orientation
modiﬁes peptide activity and/or stability with respect to salts remains to be established.
Indeed, information is still missing on the activities of Tt-BigDef and other big defensins,
precluding further interpretations. In a micellar (membrane-like) environment, the
N-terminal domain of Tt-BigDef adopts a single -helix structure, which penetrates into
micelles; it was hypothesized that insertion of this helix into target membranes may be
involved in the Tt-BigDef antimicrobial activity (11). According to our results, such a
membrane activity is not responsible for Cg-BigDef1 activity, although it could confer
antimicrobial activity to the Cg-BigDef1 N-terminal domain at a high concentration
(20 M).
The ancestral N-terminal domain of Cg-BigDef1 was shown to drive bacterially
triggered assembly of Cg-BigDef1 into nanonets, while Cg-BigDef1 appeared highly
soluble and monomeric in solution. These nanonets entrapped and killed S. aureus. The
N-terminal domain alone also produced nanonets but did not kill S. aureus. This
suggests that Cg-BigDef1 antimicrobial activity is carried by the -defensin-like domain
but requires the N-terminal domain to promote close contact with bacteria. The
mechanism by which the N-terminal drives nanonet formation remains to be charac-
terized. In human -defensin 6 (HD6), which self-assembles into elongated ﬁbrils and
agglutinates bacteria (28), hydrophobic amino acids play a key role (29). For Cg-BigDef1
to achieve self-assembly, the amino acids of the hydrophobic core need to be exposed
through a partial unfolding process or conformational change. Micelles of dodecyl-
phosphocholine induced such a conformational change of Tt-BigDef N-terminal do-
main (26). However, no report has been published on the possibility that Tt-BigDef can
form nanonets. Surprisingly, whereas the big defensin N-terminal domain was lost
during evolution toward -defensins, human BD1 (hBD1) was recently shown to form
nanonets in its reduced form (30), which is the active form of hBD1 in the colonic
environment (31). This suggests that nanonet formation may have emerged indepen-
dently in diverse families of AMPs, highlighting a neglected function of AMPs, which
can entrap bacteria and prevent subsequent host colonization (29, 30). Whether all
AMPs that self-assemble into nanonets form highly ordered structures, as observed for
HD6 in vitro (29), or protein aggregates remains unknown. According to the results of
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the HD6 study, nanonets are highly distinct from -amyloid ﬁbrils, although assembly
beneﬁts from hydrophobic interactions in both cases. The mechanisms triggering
nanonet assembly in structurally unrelated peptide families remain largely unknown. It
has been proposed for HD6 that bacterial surface proteins provide a nucleation site for
peptide self-assembly (28).
We showed here that oyster Cg-BigDef1 exerts antimicrobial activity, even at the
high physiological salt concentrations of its marine host. This salt-stable antimicrobial
activity is conferred by the hydrophobic properties of the ancestral N-terminal domain
lost in -defensins. The ability to osmoregulate, when present, is not as efﬁcient in
chelicerates and mollusks as in vertebrates, and oysters themselves are osmoconform-
ers (32, 33). Consequently, the hemolymph concentration of Na and Cl ions is very
close to their concentration in seawater. We believe that such strong selection pres-
sures imposed by marine environments could have preserved ancestral big defensins
from evolving toward (salt-sensitive) -defensins in organisms with poor control of
their blood osmolarity. In contrast, an evolutionary cost may have accelerated big
defensin molecular evolution in species that osmoregulate their body ﬂuids and have
more efﬁcient immune systems, such as vertebrates, or that live in freshwater. The only
big defensin gene present in a freshwater organism (mussel) remains a puzzling
exception (21); this gene may have evolved toward other functions after transition of
mussel species from seawater to freshwater.
Interestingly, we found that Cg-BigDef1 is active against methicillin-resistant S.
aureus at micromolar concentrations and under high salt conditions without being
FIG 8 Cg-BigDef1[1–93] and Tt-BigDef 3D structure comparison. The hydrophobic domain, the linker, and the -defensin-like domain
are colored in deep olive, red, and blue, respectively. (A) Alignment of Cg-BigDef1[1–93] (top) and Tt-BigDef (bottom) primary
sequences. Conserved residues are indicated in bold. (B) 3D structure (cartoon representation) of Cg-BigDef1[1–93] (PDB entry 6QBL).
(C) 3D structure (cartoon representation) of Tt-BigDef (PDB entry 2RNG).
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cytotoxic or proinﬂammatory toward mammalian cells. This is important, as small
peptides that self-assemble can be toxic to mammals (34). MRSA is a major cause of
mortality due to antibiotic-resistant infections (35). As antimicrobial resistance threat-
ens human health and the core of modern medicine, the WHO is calling upon the
design of new drugs active against multiresistant bacteria (36). On the basis of the
complementary action of two domains, the mechanism of action of the Cg-BigDef1
complex would be an interesting trait to explore. We can indeed speculate that grafting
the ancient N-terminal domain to vertebrate -defensin would confer high stability
with respect to salt and increase the spectrum of activity, as shown here for the two
domains of Cg-BigDef1. This reconstruction of ancient big defensins not only may have
synergistic effects, as reported for other AMP combinations (37) but may also confer a
great advantage, as resistance rises at lower rates when combinations of AMPs are used
(38). Considering the current interest in AMPs (39), we believe that analysis of ancestral
big defensins can inspire the design of novel antimicrobials that will be efﬁcient at
physiological salt concentrations but that will also be applicable for treatment of
diseases involving salt imbalance or for which salt treatment is used, such as cystic
ﬁbrosis (40).
MATERIALS AND METHODS
Database searches and sequence analysis. Sequences containing the -defensin domain were
collected from publicly accessible databases and were used for the search of homologous sequences in
both annotated and nonannotated databases (tBLASTx at NCBI). All obtained sequences were manually
inspected and translated using the ExPASy Translate Tool (http://web.expasy.org/translate/). Predictions
of signal peptides and furin-like cleavage sites were performed with the ProP 1.0 Server (http://www
.cbs.dtu.dk/services/ProP/). Multiple alignments of the deduced amino acid sequences were generated
using the MAFFT program (https://mafft.cbrc.jp/alignment/server/).
Chemical synthesis. Peptides were synthesized by solid-phase peptide synthesis on a Prelude
peptide synthesizer (Gyros-Protein Technologies) using standard Fmoc/tBu chemistry at the 25-mol
scale starting from a Tentagel resin equipped with a Rink’s amide linker and including automated
introduction of the N-2-hydroxy-5-nitrobenzyl (Hnb) group trough on resin reductive amination (22).
Cg-BigDef1 was obtained under standard conditions (19) through native chemical ligation (NCL) of an
N-terminal cysteinyl peptide segment (Cg-BigDef1[57–93]) and the crypto-thioester Cg-BigDef1[1–56]-
(Hnb)Cys(StBu). After high-performance liquid chromatography (HPLC) puriﬁcation, the reduced form
was engaged into thermodynamically controlled oxidative folding to form the three disulﬁde bridges,
using already-described protocols (41, 42). Puriﬁcation by C4 RP-HPLC afforded the pure oxidized form
of Cg-BigDef1 (see supplemental material).
Online liquid chromatography coupled to electrospray ionization tandem mass spectrometry
(LC-ESI-MS/MS). (i) Chemicals. MilliQ water (Merck Millipore, Billerica, MA) was used. LC-MS-grade
formic acid (FA), triﬂuoroacetic acid (TFA), and acetonitrile (MeCN) were from Carlo-Erba (Val de Reuil,
France). Reagent-grade chemicals for protein preparation and proline endopeptidase (E1411) were from
Sigma-Aldrich (St. Louis, MO). Sequencing-grade modiﬁed trypsin and GluC were from Promega (Mad-
ison, WI). RapiGest surfactant (SF) was from Waters (Milford, MA).
(ii) Big defensin enzymatic digestion. Synthetic peptides were digested (overnight, 37°C) by
adding RapiGest SF (0.1% to 1%) and protease (1:10 ratio). Following acidiﬁcation, the digest was dried
using a speed vacuum apparatus (FreeZone Plus 2.5-liter freeze-dry system; Labconco, Kansas City, MO,
USA) and suspended in 2% MeCN–0.1% TFA (vol/vol).
(iii) Peptide analysis by LC-ESI-MS/MS. An Agilent HPLC HP-1290 system (Agilent Technologies,
Santa Clara, CA) on-line coupled to a Q-Exactive Orbitrap mass spectrometer (Thermo Scientiﬁc, Bremen,
Germany) was used. Separation was performed on an Accucore C18 column (Thermo Scientiﬁc) (2.1 mm
by 150 mm) at 35°C with a ﬂow rate of 350 l/min. Solvent A was 0.1% FA–water and solvent B was 0.1%
FA–MeCN, and the gradient was from 2% solvent B to 15% in 26 min and then to 62% in 34 min. Typically,
volumes of 0.5 to 2 g of peptide were injected. The Q-Exactive Orbitrap mass spectrometer was
operated as previously published (43, 44) except for the automatic lock mass function (enabled on the
ion at m/z 593.15761).
NMR experiments and calculation of structures. Cg-BigDef1[44–93] and Cg-BigDef1[1–93] were
dissolved in H2O:D2O (9:1 ratio) at concentrations of 1.5 mM and 1.0 mM, respectively. pH was adjusted
to 4.6 for both samples. 2D 1H nuclear Overhauser effect spectroscopy (NOESY), 2D 1H total correlation
spectroscopy (TOCSY), band-selective optimized ﬂip angle short transient–heteronuclear multiple quan-
tum coherence (sofast-HMQC) (45) (15N natural abundance), and 13C-HSQC (13C natural abundance) were
performed at 298 K on an Avance III HD Bruker 700 MHz spectrometer equipped with a cryoprobe. 1H
chemical shifts were referenced to the water signal (4.77 ppm at 298 K). NMR data were processed using
Bruker’s Topspin 3.2 and analyzed with CCPNMR software (version 2.2.2) (46). Structures for both proteins
were calculated using the Crystallography and NMR system (CNS) suite (47, 48) through the use of ARIA2
automatic assignment software (version 2.3) (49) with NOE derived distances and hydrogen bonds and
three ambiguous disulﬁde bridges. For Cg-BigDef1[44–93], backbone dihedral angle restraints were
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added (determined with the DANGLE program [50]). See detailed protocol in Text S1 in the supplemental
material.
Strains and media. Strains and media are listed in Table S3 in the supplemental material. Marine
strains from the genera Aliivibrio, Corynebacterium, Microbacterium, and Vibrio were grown at 20°C in
liquid Zobell 1/3 medium. Other strains were grown at 30°C in liquid Poor broth (PB) medium (Table S3).
Zobell or Luria-Bertani (LB) agar plates were used as solid media.
Antimicrobial assays. (i) Determination of MICs and minimal bactericidal concentrations
(MBCs). For antibacterial assays, MICs and MBCs were determined by the liquid growth inhibition assay
previously described (51). For antifungal assays, inhibition of spore germination was monitored by a
previously described liquid growth inhibition assay (52). Synergies (FIC index) between peptides were
measured as previously described (51).
(ii) Bactericidal assays and kinetics of killing. Bacteria (105 to 106 CFU/ml) were incubated at 37°C
with or without peptide in killing buffer (KB; 0.1 M Tris [pH 8.0], 1 mM CaCl2) supplemented with 0.1%
fatty acid-free bovine serum albumin and 0 to 300mM NaCl. CFU counts were performed by plating on
LB agar plates at the indicated times. Data are expressed either as CFU per milliliter or as a percentages
of killing compared to untreated samples. Tests were performed in triplicate, and mean values were
calculated.
Membrane permeabilization assay. Stationary-phase cultures of S. aureus SG511 grown at 37°C in
LB medium were washed and resuspended at 109 CFU/ml in 10 mM phosphate-buffered saline (PBS),
supplemented with 138 mM NaCl and 2.7 mM KCl; pH was adjusted to 7.4 before addition of 1 M Sytox
green. Bacteria (100 l) were dispensed into 96-well microtiter plates containing 10 l Cg-BigDef1 (10 M
or 1.25 M ﬁnal concentration), water (negative control), or Triton X-100 (0.1% ﬁnal concentration;
positive control). Fluorescence was measured every 5 min over 4 to 6 h ( excitation [ex]  480 nm; 
emission [em]  550 nm) at 20°C. The maximum permeabilization was given by the ﬂuorescence of the
positive control.
Cytotoxicity assays. Human airway epithelial NCI-H292 cells (ATCC, Manassas, VA, USA) were
cultured in RPMI 1640 medium supplemented with 200 mM L-glutamine, 10% (vol/vol) fetal calf serum,
100 IU/ml penicillin, 100 g/ml streptomycin, and 2.5 mg/liter glucose and buffered with 25 mM HEPES
at 37°C in a humidiﬁed, 5% CO2 water-jacketed incubator. Then, the cells were cultured overnight under
serum-free conditions and treated with the peptides (5 or 20 M). After 24 h, the cell viability was
assessed by measuring the release of lactate dehydrogenase (LDH) as previously reported (22).
Assays of cytokine production. Alveolar macrophage cell line J774 cells (ATCC TIB-67, ATCC,
Manassas, VA, USA) were plated in complete RPMI medium supplemented with 1% sodium pyruvate,
200 mM L-glutamine, 10% (vol/vol) fetal calf serum, 100 IU/ml penicillin, 100 g/ml streptomycin, and
2.5 mg/liter glucose and buffered with 25 mM HEPES (pH 7.4). After 2 h, cells were incubated overnight
with fresh medium and treated with peptides (5 or 20 M) for 24 h. As a positive control for cytokine
secretion, cells were infected with P. aeruginosa PAO1. After 1 h, bacteria were removed, the cells were
reincubated in fresh culture medium for 20 h, and cytokine levels were measured by DuoSet enzyme-
linked immunosorbent assay (ELISA) kits as previously described (24).
Monitoring of peptide solubility. Stationary-phase cultures of S. aureus SG511 grown at 37°C in LB
medium were washed twice and resuspended in KB supplemented with 150 mM NaCl. Bacteria (108
CFU/ml) were treated with 5 M Cg-BigDef1[1–93], Cg-BigDef1[1–42], or Cg-BigDef1[44–93]. For nega-
tive controls, we used a same volume of water or 10% dimethyl sulfoxide (DMSO). After incubation for
30 min at 20°C, bacteria were removed by centrifugation and TFA-acidiﬁed supernatants were analyzed
by HPLC on an Agilent HPLC HP-1290 system (as described above), with an Accucore C4 column (2.1 mm
by 150 mm; ﬂow rate, 300 l/min); solvent A was 0.05% TFA–water, and solvent B was 0.04% TFA–MeCN.
The gradient consisted of an increase from 2% solvent B to 60% in 30 min, and UV detection was
performed at 225 nm.
Immunoﬂuorescence. Overnight cultures of S. aureus SG511 were washed three times to remove all
traces of culture media and adjusted to 107 CFU/ml in killing buffer (KB) before contact with Cg-
BigDef1[1–93] (5 M ﬁnal concentration). After 30 min at 25°C, bacterial cells were washed three times
in KB, centrifuged onto glass slides (10 min, 1,500 rpm), and ﬁxed for 10 min in PBS containing 4%
paraformaldehyde. After permeabilization (0.01% Triton X-100, 10 min), cells were immunostained with
a polyclonal mouse anti-Cg-BigDef1 antibody generated against the synthetic form of Cg-BigDef1[1–93].
Cells were incubated successively for 2 h with blocking solution, a 1:500 dilution of anti-Cg-BigDef1
antibody (or preimmune serum), and a 1:1,000 dilution of secondary anti-mouse antibody coupled to
Alexa Fluor 488 (Invitrogen). After three washes in PBS containing 0.05% Tween 20, cells were stained for
10 min with 0.25 g/ml DAPI (4=,6-diamidino-2-phenylindole). Coverslips were mounted with ﬂuorescent
mounting medium (Dako). Slides were observed with 63 objectives, and images were captured using
a Leica TCS SPE confocal scanning laser microscope.
Scanning electron microscopy of nanonets. Overnight cultures of S. aureus SG511 or P. aeruginosa
ATCC 9027 were washed three times in killing buffer supplemented with 150 or 300 mM NaCl. Bacterial
suspensions adjusted to an A600 of 3 were deposited on a glass slide onto peptides (5 M ﬁnal
concentration). After 24 h of incubation in a humid chamber, preparations were ﬁxed with 2.5%
glutaraldehyde. Fixed samples were dehydrated using a graded ethanol series (30% to 100%), followed
by 10 min in graded ethanol-hexamethyldisilazane and then hexamethyldisilazane alone. Subsequently,
the samples were sputter coated with an approximately 10-nm-thick gold ﬁlm and then examined under
a scanning electron microscope (Hitachi S4000; microscopy performed at CoMET, MRI-RIO Imaging,
Biocampus, INM Montpellier, Montpellier, France) using a lens detector with an acceleration voltage of
10 kV at calibrated magniﬁcations.
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Data availability. Assignments were deposited as Biological Magnetic Resonance Bank (BRMB)
entries 34345 and 34346 for Cg-BigDef1[44–93] and Cg-BigDef1[1–93], respectively. Coordinates were
deposited as PDB entries 6QBK and 6QBL for Cg-BigDef1[44–93] and Cg-BigDef1[1–93], respectively.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.01821-19.
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